Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.

The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease—a Critical Review

Open access
Sochocka, Marta, Donskow-Łysoniewska, Katarzyna, Diniz, Breno Satler, Kurpas, Donata, Brzozowska, Ewa, Leszek, Jerzy · 2019 · Molecular Neurobiology

Abstract

One of the most important scientific discoveries of recent years was the disclosure that the intestinal microflora takes part in bidirectional communication between the gut and the brain. Scientists suggest that human gut microflora may even act as the "second brain" and be responsible for neurodegenerative disorders like Alzheimer's disease (AD). Although human-associated microbial communities are generally stable, they can be altered by common human actions and experiences. Enteric bacteria, commensal, and pathogenic microorganisms, may have a major impact on immune system, brain development, and behavior, as they are able to produce several neurotransmitters and neuromodulators like serotonin, kynurenine, catecholamine, etc., as well as amyloids. However, brain destructive mechanisms, that can lead to dementia and AD, start with the intestinal microbiome dysbiosis, development of local and systemic inflammation, and dysregulation of the gut-brain axis. Increased permeability of the gut epithelial barrier results in invasion of different bacteria, viruses, and their neuroactive products that support neuroinflammatory reactions in the brain. It seems that, inflammatory-infectious hypothesis of AD, with the great role of the gut microbiome, starts to gently push into the shadow the amyloid cascade hypothesis that has dominated for decades. It is strongly postulated that AD may begin in the gut, and is closely related to the imbalance of gut microbiota. This is promising area for therapeutic intervention. Modulation of gut microbiota through personalized diet or beneficial microbiota intervention, alter microbial partners and their products including amyloid protein, will probably become a new treatment for AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12035-018-1188-4

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Age-related changes in the neuroinflmmatory response in the CNS—the role of local and peripheral infections. In healthy brain proper functioning of the brain innate immune response results in Aβ clearance and pathogen elimination [primary infection/reactivation]. Aging leads to the decline in immune surveillance and decrease of microglia fagocytic activity. Aβ overproduction/overdeposition with lose/limited antimicrobial capacity, as well as varied microbes and their products [LPS, amyloids] infecting or infiltrating into the brain from periphery, initiates the cascade of chronic neuroinflammatory reactions and neurodegenerative changes that can cause AD
Fig. 1 Age-related changes in the neuroinflmmatory response in the CNS—the role of local and peripheral infections. In healthy brain proper functioning of the brain innate immune response results in Aβ clearance and pathogen elimination [primary infection/reactivation]. Aging leads to the decline in immune surveillance and decrease of microglia fagocytic activity. Aβ overproduction/overdeposition with lose/limited antimicrobial capacity, as well as varied microbes and their products [LPS, amyloids] infecting or infiltrating into the brain from periphery, initiates the cascade of chronic neuroinflammatory reactions and neurodegenerative changes that can cause ADCC BY · PubMed Central
Fig. 2 Gut microbiota dysbiosis and Alzheimer’s disease. Mechanism and potential therapeutic interventions. The gut-brain-axis—a pathway which gut microbiota can modulate host brain function and behavior. Aging, diverse lifestyle-related risk factors, as well as different infections can induce alterations of gut microbiota [dysbiosis] increasing risks of neurodegeneration disorders such as Alzheimer’s disease. Pathogenic bacteria and their products [LPS, amyloids, nueroactive molecules] may induce increased permeability of intestine epithelial barrier and blood-brain barrier dysfunction/leak that may induce/support chronic inflmmatory reactions in the brain. From the times of Hippocrates, it is believed that there is an association between mental health and intestinal flora imballance. Possibly, modulation of gut microbiota as well as therapeutic intervention against gut microbiota dysbiosis will become a new approach to treatment for AD
Fig. 2 Gut microbiota dysbiosis and Alzheimer’s disease. Mechanism and potential therapeutic interventions. The gut-brain-axis—a pathway which gut microbiota can modulate host brain function and behavior. Aging, diverse lifestyle-related risk factors, as well as different infections can induce alterations of gut microbiota [dysbiosis] increasing risks of neurodegeneration disorders such as Alzheimer’s disease. Pathogenic bacteria and their products [LPS, amyloids, nueroactive molecules] may induce increased permeability of intestine epithelial barrier and blood-brain barrier dysfunction/leak that may induce/support chronic inflmmatory reactions in the brain. From the times of Hippocrates, it is believed that there is an association between mental health and intestinal flora imballance. Possibly, modulation of gut microbiota as well as therapeutic intervention against gut microbiota dysbiosis will become a new approach to treatment for ADCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 105 references

Cited by

See all 600

Metadata

Authors
Sochocka, M., Donskow-Łysoniewska, K., Diniz, B. S., Kurpas, D., Brzozowska, E., & Leszek, J.
Affiliations
  • Ludwik Hirszfeld Institute of Immunology and Experimental Therapy (PL)
  • The University of Texas Health Science Center at Houston (US)
  • Wroclaw Medical University (PL)
Corresponding author
Leszek, Jerzy
Venue
Molecular Neurobiology
Published
2018-06-23
Volume
56
Issue
3
Pages
1841-1851
ISSN
  • 0893-7648 (ISSN-L)
  • 1559-1182
OpenAlex
W2811371297
Cited by
584
References
105
Citations by year
2026: 40 · 2025: 80 · 2024: 84 · 2023: 79 · 2022: 115 · 2021: 84 · 2020: 70 · 2019: 22 · 2018: 9
FWCI
4.59
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • Molecular Neurobiology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, gut microbiota, gut-brain axis, dysbiosis, neuroinflammation, intestinal permeability, amyloid hypothesis, neuroactive metabolites, dietary modulation of microbiota, microbiota-based therapy
MeSH terms
Gastrointestinal Microbiome, Alzheimer Disease, Animals, Brain, Humans, Inflammation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease—a Critical Review. https://app.cochat.ai/papers/10.1007/s12035-018-1188-4
The paper
Sochocka, M., Donskow-Łysoniewska, K., Diniz, B. S., Kurpas, D., Brzozowska, E., & Leszek, J. (2019). The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease—a Critical Review. Molecular Neurobiology. https://doi.org/10.1007/s12035-018-1188-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.